1 Marc P.E. André, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Massimo Federico, University of Modena and Reggio Emilia, Modena, Italy; Catherine Fortpied, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Théodore Girinsky, Institut Gustave Roussy, Villejuif, France; Michel Meignan, Henri Mondor University Hospitals, Créteil, France; and John Raemaekers, Radboud University Medical Center, Nijmegen, the Netherlands.